Personal Finance News - Eli Lilly stock: Hurt by patent loss

With patent expirations on the horizon and health-care policy in flux, should investors consider a dose of Eli Lilly?img src="http://feeds.feedburner.com/~r/rss/money_pf/~4/1LrGIgNT7Y0" height="1" width="1"/

<b>More Info - Eli Lilly stock: Hurt by patent loss<b>